Published in Surgery Litigation and Law Weekly, March 6th, 2009
The M6-L artificial disc represents the company’s second non-fusion, motion preservation product to treat degenerative diseases of the spine. The company launched its M6-C artificial cervical disc in Europe three years ago. To date, over 3,000 discs have been implanted....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.